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Background: Improvement in the prognosis of colorectal cancer (CRC) patients has led to increasing occurrences
of multiple primary malignancies (MPMs) alongside CRC but little is known about their characteristics. This study
was undertaken to clarify the clinical and pathological features of MPMs, especially those at extra colonic sites, in
patients with CRC.
Methods: We reviewed 1,111 patients who underwent operations for primary sporadic CRC in Saitama Medical
Center, Jichi Medical University between April 2007 and March 2012. Two patients with familial adenomatous polyposis,
one with hereditary non-polyposis colorectal cancer, two with colitic cancer, and any patients with metastasis from CRC
were excluded. We compared the clinicopathological features of CRC patients with and without MPMs.
As a control, we used a database compiled of patients with gastric cancer (GC) detected by mass screening performed
in the Saitama Prefecture in Japan 2010 and compared these with CRC patients with synchronous GC.
Results: Multiple primary malignancies at extracolonic sites were identified in 117 of 1,111 CRC patients (10.5%). The
median age was 68 (range, 29 to 96) versus 71 (50 to 92) (P < 0.001). The incidence of GC (44.4% (52 of 117)) was the
highest of all MPMs. All CRC patients with GC were older than 57 years. Synchronous GC was detected in 26 patients.
By contrast, out of 200,007 screened people, 225 people were diagnosed as having GC in the Saitama Prefecture. The
age-standardized incidence of synchronous GC in CRC patients was significantly higher (0.53%) than in the control
group (0.03%) (odds ratio, 18.8; 95% confidence interval, 18.6 to 19.0; P < 0.001).
Conclusion: Patients with CRC who were older than 50 years preferentially developed GC synchronously and
metachronously. Thus, this patient group should undergo careful perioperative screening for GC.
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Colorectal cancer (CRC) is a common form of cancer in
developed countries, being the second and third leading
cause of cancer death in men and women, respectively
[1], and has become an important issue in Asian coun-
tries [2,3]. Reports from the World Health Organization
show that the incidence of CRC is rapidly rising in Asian* Correspondence: tkato@jichi.ac.jp
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unless otherwise stated.countries [2,4,5], which have experienced a two- to four-
fold increase in the incidence of CRC during the last few
decades [6]. Patients with CRC also frequently develop
multiple primary malignancies (MPMs) [7,8]. The prog-
nosis for CRC patients has steadily improved, owing to
both increased detection of early CRC and development
of new chemotherapeutic agents. The improvement in
the prognosis for CRC patients has led to an increased
incidence of MPMs [9]. It is important to understand
the characteristics of MPMs, in order to administer ap-
propriate treatment and to determine suitable follow-upis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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review the clinical and pathological features of MPMs,
especially those of extracolonic sites, in CRC patients.
Methods
Between April 2007 and March 2012, 1,111 patients
underwent surgery for primary sporadic CRC in Saitama
Medical Center, Jichi Medical University. From our data-
base of CRC patients, we extracted details of patients
who had developed at least one MPM in an extracolonic
site while having synchronous or metachronous CRC.
Synchronous MPMs were defined as malignancies de-
tected within 6-month interval before and after the
detection of CRC [9,10].
All the MPMs were pathologically or cytologically con-
firmed as malignancies. Any metastasis to extracolonic
sites from the CRC was excluded.
Two patients with familiar adenomatous polyposis, one
with hereditary non-polyposis colorectal cancer, and two
with ulcerative colitis associated colorectal cancer were
also excluded. The tumor locations of CRC were divided
into two groups: colon and rectum (portions below the
level of the sacral promontory) [11]. We reviewed clinico-
pathological parameters, such as age, sex, location of
tumor, differentiation of tumor, stage according to the
tumor, node, and metastasis (TNM) classification, of the
American Joint Committee on Cancer (6th edition) [12],
and occurrence of MPMs at extracolonic sites.
It is not known whether the incidence of gastric
cancer (GC) is higher or not in CRC patients. We per-
formed gastroscopy for CRC patients as screening
because the incidence of GC is high in Japan [13]; if GC
was discovered in CRC patients before surgery, we could
treat them by simultaneous operation. Of 1,111 patients,
832 underwent gastroscopy. These features in patients
with CRC harboring simultaneous GC were compared
with those in patients with GC that was detected by
mass screening. Screening for GC is widely spread in
Japan, a nation afflicted by high GC mortality [14]. In
1983, a national law was enacted that stipulated that
each municipality should provide annual GC screening
for inhabitants aged 40 or older, by either gastroscopy or
barium meal. In 2010, 200,007 residents (6.0% of the tar-
get population) participated in this mass screening in
the Saitama Prefecture and GC was detected in 225 pa-
tients (0.01%).
Statistical analysis
Clinical and pathological factors related to the presence
of MPMs were compared by the Mann-Whitney U test
and the χ2 test. To enable the incidence of synchronous
GC in patients with CRC to be compared, allowing for
the differences in age distributions between patients with
CRC and people who underwent screening for stomachabnormalities, as described, an age-adjusted odds ratio
was calculated, comparing the rate in patients with
synchronous GC with that in patients whose GC was
diagnosed after screening. Statistical significance was
indicated for P < 0.05.
The odds ratio was presented with 95% confidence in-
tervals. SPSS version 17 (IBM, Tokyo, Japan) was used
for statistical analyses.
In this study retrospective anonymized clinical infor-
mation from patients from the Saitama Medical Center,
Jichi Medical University were employed. The study has
been approved by the Research Ethics Committee at
Jichi Medical University.
Results and discussion
Among the 1,111 patients with primary CRC, there were
117 patients (10.5%) with MPMs. Table 1 shows the clin-
icopathological relationship between CRC patients with
and without MPMs. Patients with CRC and MPMs were
older than patients without MPMs (P < 0.001). All pa-
tients with CRC and MPMs were 50 years old or older.
There were no statistical differences between sexes,
tumor location, or differentiation of tumor. Early CRC
tended to be more associated with MPMs than advanced
CRC (P = 0.034) (Table 1 and Figure 1). Nine patients
had triple primary malignancies.
Table 2 shows the sites of the MPMs. Of 18 organs
noted to have MPMs in this study, malignancies in the
stomach were most frequently associated with CRC,
both synchronously and metachronously, followed by
lung or breast cancer.
Patients with CRC and synchronous GCs were compared
with GC patients detected by mass screening carried out in
the Saitama Prefecture in 2010 (Tables 3 and 4). The in-
cidence of synchronous GC in patients with CRC was
significantly higher than that of GC in the mass-
screened group: 2.34% versus 0.11% (Table 3 and
Figure 2). The age-adjusted odds ratio for incidence
of GC in the mass-screened group was 18.8 (95%
confidence interval, 18.6 to 19; P < 0.001) (Tables 3
and 4 and Figure 2). All patients with CRC with syn-
chronous GC were 55 years old or older. The age
distribution of all CRC patients peaked in the 70s.
Conversely, that of CRC patients with synchronous
GCs formed two peaks; one for individuals in their
60s and one for individuals who were 80 years old
or older (Figure 3).
This study demonstrates that patients with CRC are
likely to develop MPMs in extracolonic sites, the occur-
rence of which accounted for 10.5% (117/ 1,111) in our
analyses. This result is congruent with previous reports
showing the occurrence of MPMs in extracolonic sites
among CRC patients, which ranged from 2.4% to 17%
[14-17]. Moreover, our data suggest that patients with
Table 1 Comparison of clinical and pathological features between colorectal cancer patients with and without multiple
primary malignancies
Colorectal cancer without multiple
primary malignancies
Colorectal cancer with multiple
primary malignancies
Pa
(n = 994: 89.5%) (n = 117: 10.5%)
Age (years):b 68 (29 to 96) 71 (50 to 92) <0.001c
<50 79 (100) 0 (0) 0.002
≥50 915 (88.7) 117 (11.3)
Sex: 0.26
Male 627 (88.7) 80 (11.3)
Female 367 (90.8) 37 (9.2)
Tumor location: 0.345
Colon 778 (89.0) 96 (11.0)
Rectum 216 (91.1) 21 (8.9)
Differentiation: 0.678
Well or moderate 981 (89.4) 116 (10.6)
Poor 13 (92.9) 1 (7.1)
TNM stage: 0.036
I 247 (87.0) 37 (13.0)
II 333 (87.6) 47 (12.4)
III 295 (91.9) 26 (8.1)
IV 119 (94.4) 7 (5.6)
aχ2 test, except as marked; bmedian values (range); cMann-Whitney U test.
Values in parentheses are percentages unless indicated otherwise.
Figure 1 Incidence of multiple primary malignancies according
to colorectal cancer stage. 37 of 284 patients with colorectal
cancer (13%) with stage I had multiple primary malignancies, 47 of
330 patients with colorectal cancer (12.4%) had stage II, 26 of 321
patients with colorectal cancer (8.1%) had stage III and 7 of 126
patients with colorectal cancer (5.6%) had stage IV. The incidence of
multiple primary malignancies decreased with colorectal cancer
stage. MPM, multiple primary malignancy.
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those with advanced stages of CRC; this might be be-
cause the prognosis in early CRC patients is favorable,
and thus the follow-up time becomes longer than that
for advanced CRC patients. Therefore, the MPMs might
occur more often in patients with early-stage CRC than
in those with advanced CRC.
Our data showed that GC was the most frequently
associated cancer in patients with CRC both synchron-
ously and metachronously, consistent with previous re-
ports [9,10,15-19].
Note that increased surveillance for GC might appear
to increase its incidence as a result of increased detection.
Patients with CRC do seem to undergo far more testing
than the general population, including gastroscopy and
computed tomography, accounting for the high detection
rate of GC in patients with CRC [20]. As we have men-
tioned before, annual GC screening for inhabitants was
undertaken not only by gastroscopy but also by barium
meal. In some areas of the Saitama Prefecture, individuals
can choose between barium meal and gastroscopy for the
screening of GC. Out of 200,007 screened people, 56,036
people (28.0%) underwent gastroscopy in 2010. We
should agree on the difficulty of comparison between
the incidence of synchronous GC and that of screen-
detected GC. In addition, 2 of 52 patients with GC
were diagnosed with stomach cancer first. After that,
Table 2 Extracolonic site distribution of multiple primary malignancies in patients with colorectal cancer
Organ Total Percentage Number of synchronous patients with
multiple primary malignancies
Number of metachronous patients
with multiple primary malignancies
Stomach 52 39.4 26 26
Lung 17 12.9 7 10
Breast 10 7.58 0 10
Kidney 8 6.06 2 6
Esophagus 7 5.3 5 2
Prostate 7 5.3 2 5
Bladder 5 3.79 1 4
Thyroid 4 3.03 0 4
Hematologic 4 3.03 1 3
Uterus 3 2.27 1 2
Liver 2 1.52 1 1
Bile duct 2 1.52 1 1
Ovary 2 1.52 0 2
Tongue 1 0.76 0 1
Laryngeal 1 0.76 1 0
Anal fistula 1 0.76 1 0
Penis 1 0.76 0 1
Skin 1 0.76 0 1
Total 128 100 49 79
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ing colonoscopy. So, the present study has some selec-
tion bias, increasing the incidence of GC with CRC.
Consequently, it is hard to determine precisely the real
magnitude of the correlation between CRC and GC.
There are few reports of MPMs in CRC patients with
comparative data [10,17], and even then, the existing
data were calculated from a population that included
unscreened people; hence, it is far from accurate. After
calculation of prevalence using populations that con-
sist of screened subjects, we should employ this as
comparative data. Allowing for this point, we used a
database of patients with GC that was detected by
screening carried out in the Saitama Prefecture inTable 3 Comparison of clinical features between synchronous
cancer among screened group
Colorectal cancer patients with
synchronous gastric cancer
(n = 26/1,111)





aχ2 test, except as marked; bMann-Whitney U test; cage-adjusted.Japan in 2010 as comparative data, to highlight a char-
acteristic of synchronous GC with CRC. Some re-
searchers reported that screend groups were likely to
differ from unscreened groups in certain characteris-
tics, such as familial history, diet, or smoking habits
[21]. Though we could not dispute this bias, we viewed
the GC data from screened individuals as a preferable
comparison because the population included many un-
screened people. From these results, the prevalence of
synchronous GC in patients with CRC (2.6%) was
found to be extremely high, which implies that patients
with CRC are at increased risk of synchronous GC. In
addition, all patients with CRC who had synchronous










Table 4 Comparison of the incidence of gastric cancer























<40 0 22 0 4,138 Invalid value
40 to 44 0 28 1 12,659 Invalid value
45 to 49 0 29 3 11,515 Invalid value
50 to 54 0 52 3 11,729 Invalid value
55 to 59 1 110 9 16,087 16.37 (2.06, 130.48)
60 to 64 7 152 26 34,902 64.76 (27.67, 151.57)
65 to 69 6 198 56 42,917 23.92 (10.18, 56.17)
70 to 74 3 211 62 35,615 8.41 (2.62, 2701)
75 to 79 3 152 80 20,515 10.31 (3.15, 33.68)
≥80 6 157 26 9,930 15.14 (6.14, 37.31)
All ages 26 1,111 225 200,007 18.8 (18.6 to 19.0)a
aage-adjusted.
Values in parentheses are 95% confidence intervals.
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detection of GC in patients with sporadic CRC who are
older than 50 years.
In addition to the finding that the most common site
of a metachronous MPM in CRC patients is the stomachFigure 2 Comparison of the incidence between synchronous
gastric cancer in patients with colorectal cancer and gastric
cancer among screened patients according to age subgroups.
In those older than 54 years, the incidence of synchronous gastric
cancer in patients with colorectal cancer was significantly higher
than that of gastric cancer among the mass-screened group. GC,
gastric cancer.
Figure 3 Comparison of the age distributions between all patients
with colorectal cancer (top panel) and patients with colorectal
cancer with synchronous gastric cancer (bottom panel). The age
distribution of all patients with colorectal cancer peaked in the 70 to
74 years age range (211 of 1,111 patients). By contrast, that of patients
with colorectal cancer with synchronous gastric cancer formed two
peaks; among individuals 60 to 64 years old (7 of 152 patients) and
among those 80 years or older (6 of 157 patients). CRC, colorectal cancer;
GC, gastric cancer.[22], one of the most common MPMs in patients with
GC is CRC [23,24]. These facts seem to suggest that GC
and CRC share the same risk factors. In a previous
study, microsatellite instability [19], translocation of
TP53 [25,26] and ageing [22,27,28] were regarded as
shared risk factors between GC and CRC. In terms of
ageing, the median age of CRC patients with MPMs was
significantly higher than that of CRC patients without
MPMs, which agrees with those reports. Intriguingly,
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GC formed two characteristic peaks; not only was there
a peak at 80 years old or older, but there was also a peak
for people in their 60s. Familiar adenomatous polyposis
or hereditary non-polyposis colorectal cancer are given
as hereditary diseases to be complicated with GC and
CRC. We excluded patients with these diseases from our
cohort of patients with CRC by checking patients’ famil-
ial histories. Additionally, in hereditary non-polyposis
colorectal cancer, the mean age at diagnosis as CRC
is 42 to 50.4 years [29,30]. In familiar adenomatous
polyposis, without surgical intervention, patients almost
inevitably develop CRC by a mean age of 40 or 50 years
[31]. We concluded that these hereditary diseases were
less likely to be included. It is thought that there are
some factors that are not due to ageing or known
hereditary disease.
In the 18 organs that had MPMs, the lung was the sec-
ond most frequently associated with CRC, followed by
the stomach, and then the breast. In Japan, the organ
with the highest incidence of MPMs in Japan is the
stomach, followed by the colon and rectum, and then
the lung and breast [13]. This sequence matches pre-
cisely with that of MPMs in our cohort of patients
with CRC.
There are some limitations to this study. First, this re-
search was performed retrospectively. Second, our data
did not include information regarding Helicobacter pyl-
ori infection status. It is believed that 70 to 80% of
people over 40 years of age in Japan are infected with H.
pylori [32]. H. pylori infection is an important factor that
has been associated with the development of GC [33].
The incidence of H. pylori infection of the stomach in
European countries is less than that in Japan [34]. In a
European study of MPMs with CRC, cancer in the stom-
ach is far from frequent [35]. In this study, H. pylori
might contribute to the high incidence of GC with CRC.
Finally, our data did not include any information re-
garding atrophic gastritis; a previous study revealed that
atrophic gastritis might be a major cause of GC [36]. For
these reasons, additional studies are required for further
evaluation.Conclusions
Gastric cancer was the most common synchronous or
metachronous MPM in patients with CRC. Careful
perioperative screening is necessary for the detection
of MPMs in patients with CRC. However, screening for
GC is not always necessary in sporadic CRC patients
younger than 50 years.
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